Valuation SynAct Pharma AB

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-10 EDT			5-day change	1st Jan Change
21.80 ^SEK	+2.11%		+15.22%	-3.54%

07-09	Synact Pharma presents preclinical osteoarthritis data for resomelagon, shares rise	FW
07-09	Synact Pharma: Early preclinical results show resomelagon reduces osteoarthritis-related inflammation and joint damage	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,703	2,416	314.1	416.8	1,205	1,160	-	-
Change	-	-34.75%	-87%	32.69%	189.2%	-3.75%	-	-
Enterprise Value (EV) ¹	3,703	2,416	314.1	370	1,152	1,143	1,185	1,160
Change	-	-34.75%	-87%	17.8%	211.31%	-0.81%	3.71%	-2.1%
P/E	-53.1x	-22.6x	-1.33x	-4.31x	-10.4x	-14.6x	-28.7x	-
PBR	-	-	-	-	-	-	-	-
PEG	-	-0.7x	-0x	0.1x	-2.4x	0.5x	0.6x	-
Capitalization / Revenue	-	-	-	-	-	8.36x	54.8x	15.2x
EV / Revenue	-	-	-	-	-	8.23x	56x	15.2x
EV / EBITDA	-	-	-1.4x	-4.11x	-9.88x	23.7x	-39.7x	43.1x
EV / EBIT	-	-	-1.4x	-4.11x	-9.88x	23.8x	-39.6x	43.1x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.68	-3.6	-6.64	-2.08	-2.17	-1.49	-0.76	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	138.8	21.15	76.3
EBITDA ¹	-	-	-224.5	-89.98	-116.5	48.28	-29.82	26.9
EBIT ¹	-	-	-224.5	-89.98	-116.5	48.02	-29.96	26.9
Net income ¹	-69.3	-99.2	-215.8	-82.4	-110.8	52.18	-26.04	26.9
Net Debt ¹	-	-	-	-46.75	-53.41	-17.48	24.86	-
Reference price ²	142.40	81.50	8.83	8.96	22.60	21.80	21.80	21.80
Nbr of stocks (in thousands)	26,006	29,648	35,571	46,487	53,330	53,214	-	-
Announcement Date	2/11/22	2/17/23	2/23/24	2/18/25	2/18/26	-	-	-

¹SEK in Million²SEK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SYNACT PHARMA AB	-14.63x	8.23x	23.67x	-	120M
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30.1x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.78x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.02x	5.6x	31.12x	2.5%	161B
Average	13.08x	6.62x	17.18x	2.44%	357.4B
Weighted average by Cap.	23.87x	7.85x	18.16x	2%